The Preclinical Pharmacology of Tepotinib-A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations
MOLECULAR CANCER THERAPEUTICS(2023)
关键词
selective met inhibitor,tepotinib—a,tumors harboring,preclinical pharmacology
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要